Results 41 to 50 of about 346,856 (231)
Updates on interferon in juvenile dermatomyositis: pathogenesis and therapy
Current Opinion in Rheumatology, 2021 Purpose of review This review provides updates regarding the role of interferon (IFN) in juvenile dermatomyositis (JDM), including comparison to interferonopathies and therapeutic implications.
Hanna Kim
semanticscholar +1 more source
Scanning for therapeutic targets within the cytokine network of idiopathic inflammatory myopathies [PDF]
, 2015 The idiopathic inflammatory myopathies (IIM) constitute a heterogeneous group of chronic disorders that include dermatomyositis (DM), polymyositis (PM), sporadic inclusion body myositis (IBM) and necrotizing autoimmune myopathy (NAM).
De Paepe, Boel, Zschüntzsch, Jana
core +3 more sources
Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis [PDF]
Rheumatology, 2018 We examined features of clinically amyopathic JDM (CAJDM), in which patients have characteristic rashes with little to no evidence of muscle involvement, to determine whether this is a distinct phenotype from JDM.Demographic, clinical, laboratory and treatment data from 12 (9 hypomyopathic, 3 amyopathic) patients meeting modified Sontheimer criteria ...
Gulnara Mamyrova +28 more
openaire +2 more sources
Arthritis & Rheumatology, 2021 Vasculopathy is considered central to the pathogenesis of juvenile dermatomyositis (DM) and is associated with severe extramuscular manifestations.
C. Papadopoulou +7 more
semanticscholar +1 more source
Biomarkers in Inflammatory Myopathies – An Expanded Definition [PDF]
, 2019 Biomarkers as parameters of pathophysiological conditions can be of outmost relevance for inflammatory myopathies. They are particularly warranted to inform about diagnostic, prognostic, and therapeutic questions.
Benveniste, Olivier +2 more
core +3 more sources
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis
Pediatric Rheumatology Online Journal, 2022 Background We present two cases of Nodular Regenerative Hyperplasia (NRH) associated with Juvenile Dermatomyositis (JDM). Case Presentation Case 1: A nine-year-old Caucasian male with refractory JDM and anti-NXP2 autoantibodies was diagnosed at age two ...
Aviya Lanis +6 more
semanticscholar +1 more source
Clinical and autoantibody phenotypes of juvenile dermatomyositis
Rheumatology, 2022 Juvenile dermatomyositis (JDM) is a heterogeneous autoimmune inflammatory myositis with symmetrical proximal muscle weakness and a characteristic rash. Juvenile dermatomyositis is characterized by variable presentation and phenotypes.
O. Boyarchuk, Anna Kuka, Iryna Yuryk
semanticscholar +1 more source
Frontiers in Immunology, 2021 Juvenile dermatomyositis (JDM) is a rare autoimmune condition with insufficient biomarkers and treatments, in part, due to incomplete knowledge of the cell types mediating disease.
J. Neely +7 more
semanticscholar +1 more source
Resolution of calcinosis using bisphosphonates in overlap syndrome – a case report
BMC Rheumatology, 2021 Introduction Calcinosis cutis is a common complication of pediatric rheumatologic diseases. However, there is currently no consensus on first-line treatment.
Mitchell Platter +2 more
doaj +1 more source
Risk factors associated with calcinosis of juvenile dermatomyositis [PDF]
, 2008 OBJETIVO: Identificar fatores de risco associados à calcinose em crianças e adolescentes com dermatomiosite juvenil. MÉTODOS: Prontuários de 54 pacientes com dermatomiosite juvenil foram estudados.
AIKAWA, Nádia E. +6 more
core +3 more sources